Philips Respironics CoughAssist T70 airway clearance technology -- an effective alternative to traditional suctioning methods

    Philips Respironics CoughAssist T70 airway clearance technology -- an
           effective alternative to traditional suctioning methods

PR Newswire

MURRYSVILLE, Pa., Jan. 8, 2013

MURRYSVILLE, Pa., Jan. 8, 2013 /PRNewswire/ -- Philips Respironics, a unit of
Royal Philips Electronics (NYSE: PHG, AEX: PHIA), today announced that it has
received 510(k) clearance to market its latest advancement in airway clearance
technology for enhanced patient care in the hospital or in the home. The new
CoughAssist T70 provides an effective, comfortable alternative to traditional
suctioning methods and may minimize the risk of pneumonia and infections that
can lead to hospital readmissions.

To view the multimedia assets associated with this release, please click:

(Photo: )

"Philips Respironics is dedicated to providing patients, their caregivers and
clinical teams with innovative solutions that improve patient care," said Jay
Vreeland, director, North American marketing, home respiratory, Philips Home
Healthcare Solutions. "The CoughAssist T70 couples clinically-proven
technology with evolutionary enhancements that make it simpler to operate,
conveniently flexible and more sensitive to the user's breathing pattern for a
more natural treatment."

The CoughAssist T70 next generation device incorporates proven technology
that's effective, and easy to use. It clears secretions from the lungs by
gradually applying positive air pressure to the airway and then rapidly
shifting to negative air pressure. The shift in pressure creates a high
expiratory flow that simulates a deep, natural cough. Instead of introducing a
suction catheter into the airway, air is delivered through a facemask, a
mouthpiece or through a simple adapter that allows the device to function with
an endotracheal or tracheostomy tube, reducing discomfort and risk of
infection. In addition, new design and technology updates have been developed
to enhance patient and clinician use.

  oCough-Trak – A unique triggering feature with automatic sensitivity allows
    patients to initiate therapy and synchronize treatment with their own
    breathing pattern;
  oPortability – Weighing less than 9 lbs., it is compact, lightweight and
    easy to transport;
  oFlexibility – In addition to AC and DC power options, a detachable lithium
    ion battery allows up to four treatments on a single charge;
  oEase of use – A user-friendly digital interface and preset prescriptions
    simplify setup and initiating therapy;
  oResults – New data management software allows patients and caregivers to
    monitor tidal volume, peak cough flow and oxygen saturation levels to
    enhance therapy effectiveness.

The CoughAssist T70 comes with an SD card, hose clip, air filter, patient
circuit, adult mask, carrying case, and AC power cord.

Information is available online at

About Royal Philips Electronics

Royal Philips Electronics (NYSE: PHG, AEX: PHIA) is a diversified health and
well-being company focused on improving people's lives through meaningful
innovation in the areas of Healthcare, Consumer Lifestyle and Lighting.
Headquartered in the Netherlands, Philips posted 2011 sales of EUR 22.6
billion and employs approximately 121,000 employees with sales and services in
more than 100 countries. The company is a leader in cardiac care, acute care
and home healthcare, energy efficient lighting solutions and new lighting
applications, as well as male shaving and grooming, home and portable
entertainment and oral healthcare. News from Philips is located at

SOURCE Philips Respironics

Contact: Maryellen Bizzack, Philips Home Healthcare Solutions,
Press spacebar to pause and continue. Press esc to stop.